HomePatientsLung Disease Week at the ATS2011Sepsis ▶ Information for Experts
Information for Experts


Lung ATS Educational Products on Sepsis (select items below)



For more Best of ATS Conferences materials, please click here

Lung ATS Blue Journal articles on Sepsis (select abstracts listed below)

AJRCCM 2011  - Volume 184; July 2011

Activation of CXCR2 by Extracellular Matrix Degradation Product Acetylated Pro-Gly-Pro Has Therapeutic Effects against Sepsis

Read Abstract

AJRCCM 2010  - Volume 182; September 2010

Phosphoinositide-3 Kinase Y Activity Contributes to Sepsis and Organ Damage by Altering Neutrophil Recruitment

Read Abstract

AJRCCM 2010  - Volume 182; August 2010

Insulin-link Growth Factor-1 Levels Contribute to the Development of Bacterial Translocation in Sepsis

Read Abstract

AJRCCM  2007 - Volume 176; September 2007

Prophylactic Heparin in Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated)

Read Abstract

AJRCCM  2007 - Volume 176; October 2007        

The Use of Gene-Expression Profiling to Identify Candidate Genes in Human Sepsis

Read Abstract

stethoscope ATS Statements, Guidelines and Reports
ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service.

  1. An Official ATS Statement: Position Statement on ATS Activities for the Promotion of Respiratory and Sleep/Wake Health and the Care of the Critically Ill in the United States (2009)
  2. Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement (2004)
  3. Executive Summary: Management of the Critically Ill Patient with Severe Acute Pancreatitis (2004)
  4. Outcomes Research in Critical Care: Results of the ATS Critical Care Assembly Workshop on Outcomes Research (1999)